Evidence map›Paper›PMID 42514072›Full record

ArticleMicroorganisms2026

Mass Spectrometry-Based Metabolomics in Formalin-Fixed Paraffin-Embedded Skin Biopsies Identifies Potential Candidate Biomarkers for Leprosy Progression Across the Ridley-Jopling Clinical Spectrum.

Noriel Viana Pereira, Bruno de Carvalho Dornelas, Willian Vargas Tenório da Costa, João Paulo Sanches Zana, Edmundo Nunes Dos Santos Araújo, Felipe Dos Anjos Rodrigues Campos, Deiriene Rodrigues de Oliveira Campos, Tiara da Costa Silva, Hebreia Oliveira Almeida de Souza, Mário Machado Martins and 2 more

Abstract read
In one paragraph

Article in Microorganisms, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Noriel Viana PereiraGraduate Program in Health Sciences, School of Medicine, Federal University of Uberlândia, Uberlândia 38400-902, MG, Brazil.ORCID 0000-0002-6522-4705
Bruno de Carvalho DornelasPathology Unit, Hospital das Clínicas, Federal University of Uberlândia, Brazilian Hospital Services Company (HC-UFU/HU Brasil), Uberlândia 38405-302, MG, Brazil.ORCID 0000-0003-1404-8876
Willian Vargas Tenório da CostaDepartment of Anatomy and Surgery, Hospital das Clínicas, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14048-900, SP, Brazil.
João Paulo Sanches ZanaSchool of Medicine, Federal University of Uberlândia, Uberlândia 38400-902, MG, Brazil.
Edmundo Nunes Dos Santos AraújoPathology Unit, Hospital das Clínicas, Federal University of Minas Gerais, Brazilian Hospital Services Company (HC-UFMG/HU Brasil), Belo Horizonte 30130-100, MG, Brazil.
Felipe Dos Anjos Rodrigues CamposSchool of Medicine, Federal University of Uberlândia, Uberlândia 38400-902, MG, Brazil.ORCID 0000-0001-8675-6455
Deiriene Rodrigues de Oliveira CamposPathology Unit, Hospital das Clínicas, Federal University of Uberlândia, Brazilian Hospital Services Company (HC-UFU/HU Brasil), Uberlândia 38405-302, MG, Brazil.
Tiara da Costa SilvaInstitute of Exact, Natural Sciences and Education, Federal University of Triângulo Mineiro, Uberaba 38064-200, MG, Brazil.
Hebreia Oliveira Almeida de SouzaInstitute of Biotechnology, Federal University of Uberlândia, Uberlândia 38405-320, MG, Brazil.
Mário Machado MartinsInstitute of Biotechnology, Federal University of Uberlândia, Uberlândia 38405-320, MG, Brazil.ORCID 0000-0001-7381-2788
Luiz Ricardo Goulart FilhoInstitute of Biotechnology, Federal University of Uberlândia, Uberlândia 38405-320, MG, Brazil.ORCID 0000-0002-1803-4861
Isabela Maria Bernardes GoulartGraduate Program in Health Sciences, School of Medicine, Federal University of Uberlândia, Uberlândia 38400-902, MG, Brazil.

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico Resolução SES/MG nº 7.791 - 21/10/2021Fundação de Amparo à Pesquisa do Estado de Minas Gerais APQ-02810-21
6 · The paper itself

Abstract

Leprosy presents a broad clinical-immunological spectrum, whose heterogeneity challenges early diagnosis and disease stratification. Metabolomic approaches have emerged as promising tools for identifying potential biomarkers associated with the disease's pathophysiology. This study aimed to investigate metabolic profiles associated with the different clinical forms of leprosy using untargeted metabolomics in formalin-fixed paraffin-embedded (FFPE) tissue samples. A retrospective cross-sectional study was conducted with 55 patients classified according to the Ridley-Jopling spectrum. Metabolites were extracted from FFPE skin biopsies and analyzed by liquid chromatography-mass spectrometry (LC-MS). From 908 metabolites initially detected, 27 were retained after frequency filtering. Six metabolites ultimately met the criteria of one-way analysis of variance (ANOVA,

Indexed as

biopsyenzyme-linked immunosorbent assayleprosyliquid chromatography–mass spectrometrymetabolomicsMycobacterium lepraeparaffin embeddingreal-time PCR

Identifiers

PMID42514072
PMCPMC13414152

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.